Page last updated: 2024-10-27

gaboxadol and Alzheimer Disease

gaboxadol has been researched along with Alzheimer Disease in 2 studies

gaboxadol: GABA agonist; inhibitor of GABA uptake systems; structure

Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dissel, S1
Angadi, V1
Kirszenblat, L1
Suzuki, Y1
Donlea, J1
Klose, M1
Koch, Z1
English, D1
Winsky-Sommerer, R1
van Swinderen, B1
Shaw, PJ1
Mohr, E1
Bruno, G1
Foster, N1
Gillespie, M1
Cox, C1
Hare, TA1
Tamminga, C1
Fedio, P1
Chase, TN1

Trials

1 trial available for gaboxadol and Alzheimer Disease

ArticleYear
GABA-agonist therapy for Alzheimer's disease.
    Clinical neuropharmacology, 1986, Volume: 9, Issue:3

    Topics: Alzheimer Disease; Clinical Trials as Topic; gamma-Aminobutyric Acid; Humans; Isoxazoles; Middle Age

1986

Other Studies

1 other study available for gaboxadol and Alzheimer Disease

ArticleYear
Sleep restores behavioral plasticity to Drosophila mutants.
    Current biology : CB, 2015, May-18, Volume: 25, Issue:10

    Topics: Adenylyl Cyclases; Alzheimer Disease; Animals; Animals, Genetically Modified; Behavior, Animal; Dise

2015